By Brevan Branscum | Phoenix Business Journal
Arizona is set to become a global leader in psilocybin research.
Scottsdale Research Institute announced on May 28 that it will lead the first government-funded study measuring the effects of natural psilocybin mushrooms when treating individuals with life-threatening illnesses. The initiative will proceed after SRI, led by President Sue Sisley, MD, was awarded roughly $2.75 million of a $5 million grant that Arizona leaders had previously dedicated to natural psilocybin research.
“AZ has unique opportunity to provide its citizens with safe legal access to another natural medicine. Dr. Sisley’s study will no doubt add to the growing mountain of evidence regarding the efficacy of psilocybin mushrooms for a wide range of mental health treatments but it is unconscionable to continue to force sick people to break the law while we wait for the federal government to do the right thing. The AZ legislature should immediately pass a functional and reasonable bill allowing patients to access this medicine legally. It worked with cannabis it is the right thing to do with psylocibin.”
-Rose Law Group Cannabis Department Chair Ryan Hurley
